OKUR (OnKure Therapeutics) Additional Paid-In Capital : $261.30 Mil(As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is OnKure Therapeutics Additional Paid-In Capital?

OnKure Therapeutics's quarterly additional paid-in capital declined from Sep. 2024 ($309.97 Mil) to Dec. 2024 ($258.55 Mil) but then increased from Dec. 2024 ($258.55 Mil) to Mar. 2025 ($261.30 Mil).

OnKure Therapeutics's annual additional paid-in capital declined from Dec. 2022 ($2.66 Mil) to Dec. 2023 ($0.21 Mil) but then increased from Dec. 2023 ($0.21 Mil) to Dec. 2024 ($258.55 Mil).

OnKure Therapeutics Additional Paid-In Capital Historical Data

The historical data trend for OnKure Therapeutics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OnKure Therapeutics Additional Paid-In Capital Chart

OnKure Therapeutics Annual Data

Trend

Dec22

Dec23

Dec24

Additional Paid-In Capital

2.66

0.21

258.55

OnKure Therapeutics Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Additional Paid-In Capital	Get a 7-Day Free Trial					0.33	2.15	309.97	258.55	261.30

OnKure Therapeutics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

OnKure Therapeutics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of OnKure Therapeutics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

OnKure Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

6707 Winchester Circle, Suite 400, Boulder, CO, USA, 80301

Website

https://www.onkuretherapeutics.com

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.